Pzena Investment Management LLC Decreases Stake in Humana Inc. $HUM

Pzena Investment Management LLC cut its position in Humana Inc. (NYSE:HUM) by 1.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,031,083 shares of the insurance provider’s stock after selling 45,584 shares during the quarter. Humana comprises 3.4% of Pzena Investment Management LLC’s investment portfolio, making the stock its 9th biggest position. Pzena Investment Management LLC owned about 3.35% of Humana worth $1,048,767,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in HUM. Unison Advisors LLC grew its position in Humana by 0.4% during the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock worth $2,646,000 after buying an additional 37 shares in the last quarter. Private Wealth Management Group LLC grew its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares in the last quarter. Ossiam grew its holdings in shares of Humana by 1.6% during the second quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock worth $1,070,000 after purchasing an additional 71 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Humana by 15.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 518 shares of the insurance provider’s stock worth $135,000 after purchasing an additional 71 shares during the last quarter. Finally, Signaturefd LLC raised its stake in Humana by 4.7% in the third quarter. Signaturefd LLC now owns 1,626 shares of the insurance provider’s stock valued at $423,000 after purchasing an additional 73 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft set a $180.00 price target on shares of Humana and gave the stock a “hold” rating in a report on Friday, February 13th. Jefferies Financial Group lowered their price target on Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Oppenheimer set a $250.00 price target on Humana in a research note on Thursday, February 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Thursday, January 22nd. Finally, Robert W. Baird decreased their price objective on Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a report on Thursday, December 11th. Seven analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $228.48.

Humana Stock Up 1.4%

HUM opened at $187.52 on Thursday. Humana Inc. has a 12 month low of $169.61 and a 12 month high of $315.35. The company has a current ratio of 2.00, a quick ratio of 2.02 and a debt-to-equity ratio of 0.70. The business’s 50-day moving average price is $240.52 and its 200-day moving average price is $259.61. The company has a market cap of $22.55 billion, a P/E ratio of 19.10, a P/E/G ratio of 1.98 and a beta of 0.44.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating the consensus estimate of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.Humana’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the business posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.